Core Viewpoint - The stock of Innovent Biologics-B (09939) has seen an increase of over 3%, currently trading at 3.01 HKD with a transaction volume of 8.0533 million HKD, following an announcement regarding share buyback by the company's chairman, Dr. Hui Zhi Tong [1] Group 1 - On January 26, Innovent Biologics-B announced that its board received notification from Dr. Hui Zhi Tong, the chairman, executive director, and CEO, regarding a share buyback plan [1] - Dr. Hui plans to acquire approximately 10.82 million HKD worth of shares through his wholly-owned company, KT International Investment Limited, in the open market, at an average price of 2.30 HKD per share, with a price range of 1.89 HKD to 2.81 HKD [1] - The buyback will involve 4.7 million shares, representing about 0.9425% of the total issued share capital as of the announcement date [1] Group 2 - Dr. Hui expressed confidence in the overall development prospects and commercialization transformation of the company [1] - He does not rule out the possibility of further increasing his stake in the company after the silent period, which ends on March 26, 2026 [1]
港股异动 | 开拓药业-B(09939)盘中涨超3% 获董事会主席童友之增持470万股公司股份